Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma (Q43678686)

25 November 2017

title

Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma (English)

1 reference

25 November 2017

0 references

8

1 reference

25 November 2017

Theofilos Poutahidis

1

1 reference

25 November 2017

Kevin M Haigis

2

1 reference

25 November 2017

Varada P Rao

3

1 reference

25 November 2017

Prashant R Nambiar

4

1 reference

25 November 2017

Christie L Taylor

5

1 reference

25 November 2017

Zhongming Ge

6

1 reference

25 November 2017

Koichiro Watanabe

7

1 reference

25 November 2017

Bruce H Horwitz

9

1 reference

25 November 2017

James G Fox

10

1 reference

25 November 2017

Susan E Erdman

11

1 reference

25 November 2017

language of work or name

English

0 references

publication date

27 August 2007

1 reference

25 November 2017

1 reference

25 November 2017

volume

28

1 reference

25 November 2017

issue

12

1 reference

25 November 2017

page(s)

2614-2623

1 reference

Is mucinous carcinoma of the colorectum a distinct genetic entity?

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Colloid carcinoma of the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

CD4 CD25 regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

T cells in inflammatory bowel disease: protective and pathogenic roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

CD4 CD25 T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Pathology of mouse models of intestinal cancer: consensus report and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4( ) TH1-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Clonogenic growth of epithelial cells from normal colonic mucosa from both mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Cure of innate intestinal immune pathology by CD4 CD25 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Bacteria-triggered CD4( ) T regulatory cells suppress Helicobacter hepaticus-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

FOXP3 regulatory T cells: Current controversies and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Peripheral and intestinal regulatory CD4 CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Proinflammatory CD4 CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/ ) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Interleukin-6 trans-signalling in chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Immunology. Regulating the regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

CD4 CD25 regulatory lymphocytes induce regression of intestinal tumors in ApcMin/ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

IL-10-producing and naturally occurring CD4 Tregs: limiting collateral damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Wound healing--aiming for perfect skin regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Review of case definitions for nosocomial infection--towards a consensus. Presentation by the Nosocomial Infection Surveillance Unit (NISU) to the Hospital Infection Liaison Group, subcommittee of the Federation of Infection Societies (FIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Role of transforming growth factor beta in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Colitis is associated with thymic destruction attenuating CD4 25 regulatory T cells in the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 CD25 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

Essential role for oncogenic Ras in tumour maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGM180

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGM180

1 reference

25 November 2017

1 reference